Celiac Disease Management in Children

Diagnostic Confirmation

The American Academy of Pediatrics and other medical societies recommend diagnosis through measurement of IgA tissue transglutaminase (tTG) antibodies with documentation of normal total serum IgA levels 1, 2
In cases of IgA deficiency, IgG tTG and deamidated gliadin antibodies should be measured instead, as suggested by the European Society for Pediatric Gastroenterology 2, 3
A small bowel biopsy is recommended in antibody-positive children to confirm diagnosis before establishing significant dietary changes, according to the American Gastroenterological Association 1, 2
European guidelines suggest biopsy may not be necessary in symptomatic children with antibody titers greater than 10 times the upper limit of normal, provided that endomysial antibody positivity is verified on a separate blood sample, as stated by the European Society for Pediatric Gastroenterology 1, 2

The American Academy of Pediatrics recommends immediately referring newly diagnosed patients to a dietitian experienced in managing both celiac disease and pediatric nutrition for assessment and counseling about implementing a gluten-free diet 4, 3
Test for micronutrient deficiencies including iron, folate, vitamin D, and vitamin B12, which are common in celiac disease, as suggested by the American Academy of Family Physicians 4
Monitor growth parameters (height and weight) closely, as poor growth can be a sign of ongoing disease activity or nutritional deficiencies, according to the American Academy of Pediatrics 1, 3

The American Academy of Family Physicians recommends strictly avoiding all products containing wheat, barley, and rye proteins for life 4
Pure oats may be safe for most children with celiac disease but should be introduced slowly with careful monitoring for adverse reactions, as suggested by the American Gastroenterological Association 4

The American Academy of Family Physicians recommends scheduling regular follow-up visits every 6-12 months to monitor adherence to the gluten-free diet 4
Use a combination of history, serology, and dietitian assessment to monitor dietary adherence, as suggested by the American Academy of Pediatrics 4
Repeat screening for celiac antibodies to assess dietary adherence and disease activity, according to the European Society for Pediatric Gastroenterology 1, 2

For patients with persistent or relapsing symptoms despite a gluten-free diet, review dietary history for inadvertent gluten exposure, as recommended by the American Gastroenterological Association 4
Consider upper endoscopy with duodenal biopsies if symptoms persist despite apparent adherence to gluten-free diet, as suggested by the American Academy of Family Physicians 4

The challenging dietary restrictions associated with having both celiac disease and other conditions (like type 1 diabetes) place a significant burden on children and families, according to the American Diabetes Association 1, 3

In children with total IgA deficiency, IgG‑based serologic assays (IgG tissue transglutaminase or IgG endomysial antibodies) should be used instead of IgA‑based tests to avoid false‑negative results. 5
IgG deamidated gliadin peptide (DGP) antibodies add diagnostic value in IgA‑deficient patients, helping to identify celiac disease when IgA‑based assays are unreliable. 5

HLA‑DQ2/DQ8 genotyping is recommended when serologic results are equivocal or when the patient has already started a gluten‑free diet, because a negative HLA result effectively excludes celiac disease. 6

The child must remain on a regular gluten‑containing diet (e.g., at least three slices of wheat bread daily) until all serologic and histologic testing is completed, as gluten avoidance reduces the sensitivity of both antibody assays and duodenal biopsies. 6
If the patient has reduced gluten intake before testing, normal gluten consumption should be resumed for 1–3 months before repeat serology or biopsy. 6

A thorough medication history should be obtained, specifically noting the use of angiotensin II receptor blockers such as olmesartan, which can cause villous atrophy that mimics celiac disease. 5

When tTG‑IgA is positive, an esophagogastroduodenoscopy with duodenal biopsies is required to confirm the diagnosis before initiating a gluten‑free diet. 7

Baseline growth parameters (height and weight) should be documented at diagnosis, as they serve as essential markers of treatment success in children. 7

Growth parameters must be monitored at each follow‑up visit; satisfactory increases in weight and height indicate effective disease control in pediatric patients. 7
Routine vitamin and mineral testing is not necessary in children who attend regular follow‑up, demonstrate normal growth, and are asymptomatic. 8

Adolescents are at higher risk for reduced dietary adherence, lower satisfaction with disease impact, and loss to follow‑up, which correlates with persistent antibody positivity. Early, age‑appropriate counseling and close follow‑up are essential to prevent long‑term complications such as malabsorption, anemia, and osteoporosis. 9